Carfilzomib – USA

Carfilzomib – USA

On Mar. 08, 2021, Federal Circuit affirmed (Rule 36 judgment) Delaware district court & found patents valid in a Hatch-Waxman suit. You can read the detailed district court summary “reported here” on this blog.

 

Leave a Reply

Leave a Reply

Your email address will not be published.

Disclaimer
All content provided on this blog is for informational purposes only. By using the blog, you agree that the information on this blog does not constitute legal or other professional advice on author's or on his company's behalf.

Copyrights 2022 Pharma IP Circle. All Rights Reserved